Matches in SemOpenAlex for { <https://semopenalex.org/work/W2279054906> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2279054906 endingPage "31" @default.
- W2279054906 startingPage "924" @default.
- W2279054906 abstract "To evaluate the effectiveness and safety of a single thermodynamic treatment system (LipiFlow) for meibomian gland dysfunction (MGD).Retrospective series case study. Forty-eight subjects with meibomian gland dysfunction were analyzed before and after 12 minutes LipiFlow system treatment. All subjects were examined before, 4 weeks and 12 weeks after this treatment. Subjective symptoms, lipid layer thickness (LLT), expressible meibomian gland, tear break-up time, meibomian gland assessment and ocular surface staining were measured. Statistical analysis was performed using SPSS 11.5 software. Analysis included those independent sample two-tailed t-tests for comparison of the mean change from baseline to 4 weeks and baseline to 12 weeks after Lipiflow treatment. Statistically significant difference was based on α=0.05 (P<0.05).A total of 48 cases completed the 12-week follow-up. MGD patients with LipiFlow treatment had a significant reduction in the Ocular Surface Disease Index (OSDI) scores with 45.36±19.34 before treatment, 23.82±11.94 at 4 weeks (t=2.009, P=0.035) and 25.66±14.12 at 12 weeks (t=1.976 P=0.038). LipiFlow resulted in a higher number of expressible glands from 2.91±1.13 (baseline) to 6.27±2.37 (4 weeks, t=3.505, P<0.001) and 5.15±2.08 (12 weeks, t=2.004, P= 0.027) and change of secretion quality from 6.18±2.48 (baseline) to 13.55±3.46 (4 weeks,t=2.698,P=0.005) and 12.67±3.41 (12 weeks,t=2.403,P=0.009). In addition, a single thermodynamic treatment increase the LLT from (42.13±9.67)nm (baseline) to (59.02±16.39)nm (4 weeks, t=2.971, P=0.002) and (54.65±12.52)nm (12 weeks, t=2.021, P=0.021). The rate of partial blink was relieved from 0.37±0.30 (baseline) to 0.15±0.14 (4 weeks, t=3.428, P=0.035) and 0.12±0.13 (12 weeks, t=1.986, P=0.026). BUT was increased from (4.73± 2.34)s (baseline) to (9.32 ± 2.18)s (4 weeks, t=3.385, P<0.001) and (9.91 ± 3.01)s (12 weeks, t=3.253, P< 0.001). There were no unanticipated or serious device-related adverse events reported. Compared with baseline, there was no statistically significant difference in BCVA, corneal staining and intraocular pressure (P=0.141, 0.376, 0.421).The LipiFlow system was a safety and effectiveness treatment of MGD in the 12-week study." @default.
- W2279054906 created "2016-06-24" @default.
- W2279054906 creator A5008464944 @default.
- W2279054906 creator A5025110659 @default.
- W2279054906 creator A5026906414 @default.
- W2279054906 creator A5059564497 @default.
- W2279054906 creator A5072208221 @default.
- W2279054906 creator A5075764624 @default.
- W2279054906 creator A5076905446 @default.
- W2279054906 date "2015-12-01" @default.
- W2279054906 modified "2023-10-01" @default.
- W2279054906 title "[Clinical evaluation of a thermodynamic treatment system for meibomian gland dysfunction]." @default.
- W2279054906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26888275" @default.
- W2279054906 hasPublicationYear "2015" @default.
- W2279054906 type Work @default.
- W2279054906 sameAs 2279054906 @default.
- W2279054906 citedByCount "2" @default.
- W2279054906 countsByYear W22790549062020 @default.
- W2279054906 countsByYear W22790549062022 @default.
- W2279054906 crossrefType "journal-article" @default.
- W2279054906 hasAuthorship W2279054906A5008464944 @default.
- W2279054906 hasAuthorship W2279054906A5025110659 @default.
- W2279054906 hasAuthorship W2279054906A5026906414 @default.
- W2279054906 hasAuthorship W2279054906A5059564497 @default.
- W2279054906 hasAuthorship W2279054906A5072208221 @default.
- W2279054906 hasAuthorship W2279054906A5075764624 @default.
- W2279054906 hasAuthorship W2279054906A5076905446 @default.
- W2279054906 hasConcept C118487528 @default.
- W2279054906 hasConcept C126322002 @default.
- W2279054906 hasConcept C2777165675 @default.
- W2279054906 hasConcept C2781302119 @default.
- W2279054906 hasConcept C71924100 @default.
- W2279054906 hasConcept C90924648 @default.
- W2279054906 hasConceptScore W2279054906C118487528 @default.
- W2279054906 hasConceptScore W2279054906C126322002 @default.
- W2279054906 hasConceptScore W2279054906C2777165675 @default.
- W2279054906 hasConceptScore W2279054906C2781302119 @default.
- W2279054906 hasConceptScore W2279054906C71924100 @default.
- W2279054906 hasConceptScore W2279054906C90924648 @default.
- W2279054906 hasIssue "12" @default.
- W2279054906 hasLocation W22790549061 @default.
- W2279054906 hasOpenAccess W2279054906 @default.
- W2279054906 hasPrimaryLocation W22790549061 @default.
- W2279054906 hasRelatedWork W2022479428 @default.
- W2279054906 hasRelatedWork W210696140 @default.
- W2279054906 hasRelatedWork W2317774021 @default.
- W2279054906 hasRelatedWork W2385476805 @default.
- W2279054906 hasRelatedWork W2622079263 @default.
- W2279054906 hasRelatedWork W2900045077 @default.
- W2279054906 hasRelatedWork W3030649320 @default.
- W2279054906 hasRelatedWork W3031363963 @default.
- W2279054906 hasRelatedWork W4282960222 @default.
- W2279054906 hasRelatedWork W4287921910 @default.
- W2279054906 hasVolume "51" @default.
- W2279054906 isParatext "false" @default.
- W2279054906 isRetracted "false" @default.
- W2279054906 magId "2279054906" @default.
- W2279054906 workType "article" @default.